J.W. Cole Advisors, Inc. Biomarin Pharmaceutical Inc Transaction History

J.W. Cole Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $219,126 - $273,435	-2,950 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$71.72 - $91.47 $139,854 - $178,366	-1,950 Reduced 39.8%	2,950 $261,000
Q3 2021 Oct 26, 2021	BUY	$74.77 - $85.47 $366,373 - $418,803	4,900 New	4,900 $379,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.